Last reviewed · How we verify
NCT04117737
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
NA trial testing Virtual reality combined with anti-gravity treadmill in Parkinson Disease in 12 participants. Completed in 30 December 2019.
30 November 2019
Quick facts
| Lead sponsor | Universidad San Jorge |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 30 September 2019 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Virtual reality combined with anti-gravity treadmill
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Gait Disorders, Neurologic — all drugs for Gait Disorders, Neurologic →
Sponsor
Universidad San Jorge
Who can join
Adults 18 to 90, any sex, with Parkinson Disease or Gait Disorders, Neurologic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to improve knowledge about mechanical gait assistance combined with virtual reality efficiency in gait recovery for Parkinson´s patients. It is hypothesised that 12 sessions of 30 minutes each, over a 4 weeks period, of antigravity treadmill rehabilitation combined with virtual reality treatment is effective for increase gait autonomy in patients with Parkinson's disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04117737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Universidad San Jorge trials
Trials by the same sponsor.
- NCT07360626 — Exercise and Health Education for Textile Workers: A Pre-Post Study · NA · recruiting
- NCT06820073 — Effects of GPR with K-Stretch Hammock on Posture and Musculoskeletal Discomfort · NA · recruiting
- NCT05543408 — Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial" · NA · unknown
- NCT04794036 — Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient · NA · completed
- NCT04235088 — Impact of Somatosensory Intensive Intervention on Motor Performance in Children With Unilateral Cerebral Palsy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04117737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad San Jorge
- Last refreshed: 28 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04117737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing